GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| ||||||||||||||||||||||
| Name | Date | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes & Obesity Drug Development Pipeline Review, 2016 | Dec 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Diabetes & Obesity Drug Development Pipeline Review, #### Published: December #### Report Code: GBIHC###IDB www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied GBIHC###IDB / Published DEC #### Page # GBI Research Report... | ||||||||||||||||||||||
| Ophthalmology Drug Development Pipeline Review, 2016 | Dec 01, 2016 | |||||||||||||||||||||
| ...Ophthalmology Drug Development Pipeline Review, #### Report Code: GBIHC####IDB Published: December #### www.gbiresearch.com THERAPY ANALYSIS © GBI Research. This is a licensed product and is not to be photocopied GBIHC####IDB / Published DEC #### Page # GBI Research Report Guidance... | ||||||||||||||||||||||
| Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 | Nov 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Cancer Vaccines Market to #### Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD## Report Code: GBIHC###MR Published: November #### www.gbiresearch.com © GBI Research. This is a licensed... | ||||||||||||||||||||||
| Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation | Nov 01, 2016 | |||||||||||||||||||||
| ...FRONTIER PHARMA Asthma Therapeutics Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in- Class Innovation Published: November #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not... | ||||||||||||||||||||||
| Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy | Nov 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Hemophilia A and B Therapeutics in Asia-Pacific Markets to #### - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long- Acting Replacement Therapies and Non-factor Therapy Report Code: GBIHC###MR Published: November #### www.gbiresearch.com © GBI... | ||||||||||||||||||||||
| Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth | Oct 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Cardiovascular Disease Market to #### Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Report Code: GBIHC###MR Published: October #### www.gbiresearch.com © GBI Research. This is a licensed product and is... | ||||||||||||||||||||||
| Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape | Sep 13, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Gastrointestinal Drug Market to #### Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Report Code: GBIHC###MR Published: September #### www.gbiresearch.com © GBI Research. This is a licensed product... | ||||||||||||||||||||||
| Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way | Sep 01, 2016 | |||||||||||||||||||||
| ...Ophthalmology Therapeutics Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way Published: September #### Report Code: GBIHC###MR www.gbiresearch.com FRONTIER PHARMA © GBI Research. This is a licensed... | ||||||||||||||||||||||
| Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies | Sep 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Gastric Cancer Therapeutics in Asia-Pacific Markets to #### - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Report Code: GBIHC###MR Published: September #### www.gbiresearch.com © GBI Research. This is a licensed product and is not... | ||||||||||||||||||||||
| Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation | Sep 01, 2016 | |||||||||||||||||||||
| ...FRONTIER PHARMA Glioblastoma Multiforme Cancer Immunotherapies Dominate First-in-Class Product Innovation Published: September #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Image Credit: Snyder, ####] GBIHC###MR / Published... | ||||||||||||||||||||||
| Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth | Aug 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Type # Diabetes Mellitus Therapeutics in South-East Asia Markets to #### - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Report Code: GBIHC###MR Published: August #### www.gbiresearch.com © GBI Research. This is... | ||||||||||||||||||||||
| Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way | Aug 01, 2016 | |||||||||||||||||||||
| ...Global Respiratory Drugs Market to #### Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way Report Code: GBIHC###MR Published: August #### www.gbiresearch.com THERAPY ANALYSIS © GBI Research. This is a... | ||||||||||||||||||||||
| Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment | Aug 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Diabetes and Obesity Drugs Market to #### Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Report Code: GBIHC###MR Published: August #### www.gbiresearch.com © GBI Research. This is a licensed... | ||||||||||||||||||||||
| Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation | Aug 01, 2016 | |||||||||||||||||||||
| ...FRONTIER PHARMA Rheumatoid Arthritis Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Published: August #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published AUG... | ||||||||||||||||||||||
| Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period | Aug 01, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Ophthalmology Drugs Market to #### Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period Report Code: GBIHC###MR Published: August #### www.gbiresearch.com © GBI Research. This is a licensed product and is not... | ||||||||||||||||||||||
| Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes | Aug 01, 2016 | |||||||||||||||||||||
| ...Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes FRONTIER PHARMA Published: August #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is... | ||||||||||||||||||||||
| Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies | Jul 04, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Osteoporosis Therapeutics in Asia-Pacific Markets to #### Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies Report Code: GBIHC###MR Published: July #### www.gbiresearch.com © GBI Research. This is a licensed product and... | ||||||||||||||||||||||
| Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics | Jun 16, 2016 | |||||||||||||||||||||
| ...THERAPY ANALYSIS Global Urological Cancer Market to #### - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics Report Code: GBIHC###MR Published: June #### www.gbiresearch.com © GBI Research. This is a licensed product... | ||||||||||||||||||||||
| Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies | Jun 01, 2016 | |||||||||||||||||||||
| ...FRONTIER PHARMA Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies Published: June #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied... | ||||||||||||||||||||||
| Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies | Jun 01, 2016 | |||||||||||||||||||||
| ...FRONTIER PHARMA Hematological Cancers Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Published: June #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUN ####... | ||||||||||||||||||||||
